
|Articles|June 16, 2017
Covance Opens Lab for Companion Diagnostics
Advertisement
LabCorp announced that its Covance Drug Development business will open a companion diagnostics lab in Morrisville, North Carolina.
The facility also includes a genomics and molecular pathology lab to support clinical trials and diagnostic testing development, and a nuclear magnetic resonance (NMR) laboratory that houses an NMR spectrometer, approved by the FDA. The site also houses manufacturing facilities for diagnostics materials and testing components.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
5




